Published in J Kidney Cancer VHL on August 02, 2017
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (1999) 23.45
von Hippel-Lindau disease. Lancet (2003) 6.20
The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer. Nat Rev Cancer (2008) 4.42
von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet (2011) 2.45
von Hippel-Lindau disease. Surv Ophthalmol (2001) 1.82
Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses. J Urol (2012) 1.80
pVHL19 is a biologically active product of the von Hippel-Lindau gene arising from internal translation initiation. Proc Natl Acad Sci U S A (1998) 1.74
Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup. J Urol (2010) 1.67
Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery (2007) 1.67
Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat (2007) 1.66
Von Hippel-Lindau disease. Lancet (2004) 1.50
Neurologic manifestations of von Hippel-Lindau disease. JAMA (2008) 1.26
Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet (2012) 1.20
Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol (2009) 1.17
Management of von Hippel-Lindau disease-associated CNS lesions. Expert Rev Neurother (2011) 1.16
Surgical resection of endolymphatic sac tumors in von Hippel-Lindau disease: findings, results, and indications. Laryngoscope (2012) 0.98
Surveillance in von Hippel-Lindau disease (vHL). Clin Genet (2009) 0.96
Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg (2014) 0.94
Manifestations of Von Hippel Lindau syndrome: a retrospective national review. QJM (2013) 0.90
Von Hippel-Lindau disease. Handb Clin Neurol (2015) 0.89
Von Hippel-Lindau disease. Eur J Cancer (1994) 0.85
Preimplantation genetic diagnosis (PGD) for heritable neoplasia. J Natl Cancer Inst Monogr (2005) 0.81
Endocrine manifestations of von Hippel-Lindau disease. Arch Pathol Lab Med (2015) 0.81
Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma. J Kidney Cancer VHL (2015) 0.78
von Hippel-Lindau Disease: Review of Genetics and Imaging. Radiol Clin North Am (2016) 0.77